Results 221 to 230 of about 29,062 (270)

Synthesis and computational evaluation of the antioxidant activity of pyrrolo[2,3-b]quinoxaline derivatives. [PDF]

RSC Adv
Nguyen NT, Dai VV, Mechler A, Van Meervelt L, Hoa NT, Vo QV.   +5 more
europepmc   +1 more source

Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide derivatives as potential antitubercular agents. [PDF]

RSC Med Chem
González-González A, Sánchez-Sánchez O, Wan B, Franzblau S, Palos I, Espinoza-Hicks JC, Moreno-Rodríguez A, Martínez-Vázquez AV, Lara-Ramírez EE, Ortiz-Pérez E, Paz-González AD, Rivera G.   +11 more
europepmc   +1 more source

Anticancer, anti-inflammatory and analgesic activities of aminoalcohol-based quinoxaline small molecules. [PDF]

Acta Cir Bras
Neri JM, Siqueira PEA, Oliveira ALCSL, Araújo RM, Araújo Júnior RF, Martins AA, Marques IL, Silva RA, Araújo AA, Menezes FG.   +9 more
europepmc   +1 more source

Beiträge zur Synthese des cyclischen Pyranopterin-Monophosphats (cPMP) und seiner Analoga [PDF]

, 2013
Kaletta, Florian
core  

Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity. [PDF]

Int J Mol Sci
Corona P, Gessi S, Ibba R, Merighi S, Mirandola P, Pinna GA, Nigro M, Pozzi G, Asproni B, Travagli A, Piras S, Carta A, Caria P, Murineddu G.   +13 more
europepmc   +1 more source

Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1,4-dioxides as carbonic anhydrase inhibitors. [PDF]

RSC Adv
Buravchenko GI, Scherbakov AM, Krymov SK, Salnikova DI, Zatonsky GV, Schols D, Vullo D, Supuran CT, Shchekotikhin AE.   +8 more
europepmc   +1 more source

Removal of As(V) and Cr(VI) using quinoxaline chitosan schiff base: synthesis, characterization and adsorption mechanism. [PDF]

BMC Chem
Abdelwahab HE, Elhag M, El Sadek MM.
europepmc   +1 more source

Computational framework for discovery of degradation mechanisms of organic flow battery electrolytes. [PDF]

Chem Sci
Zhang X, de Silva P.
europepmc   +1 more source

Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models. [PDF]

Cell Death Dis
Bigot K, Patinote C, Garambois V, Chouchou A, Gayraud-Paniagua S, Vie N, Maggipinto Y, Smyej E, Robin M, Machu M, Bruciamacchie M, Colombo PE, Bousquet C, Mathonnet M, Levy-Augé E, Tosi D, Bonnet PA, Gongora C, Deleuze-Masquéfa C, Larbouret C.   +19 more
europepmc   +1 more source